Cargando…
Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study
PURPOSE: Metastatic cervical cancer has a poor prognosis, and treatment options are limited. Immunotherapy has been used to achieve disease control in patients with cervical cancer; however, the efficacy of immunotherapy retreatment after disease progression is unclear. This study aimed to explore t...
Autores principales: | Li, Guiling, Cheng, Mingxia, Hong, Kai, Jiang, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999713/ https://www.ncbi.nlm.nih.gov/pubmed/36911534 http://dx.doi.org/10.2147/OTT.S400376 |
Ejemplares similares
-
Pretreatment Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase Predict the Prognosis of Metastatic Cervical Cancer Treated with Combination Immunotherapy
por: Cheng, Mingxia, et al.
Publicado: (2022) -
Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
por: Wong, Adriana J., et al.
Publicado: (2022) -
Efficacy and Prognostic Factors for Response to PD-1 Inhibitors in Advanced Cervical Carcinoma: A Retrospective Study
por: Cheng, Mingxia, et al.
Publicado: (2022) -
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
por: Amatu, Alessio, et al.
Publicado: (2022) -
Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials
por: Schmidt, Mona W., et al.
Publicado: (2022)